Skip to content

OxySure Therapeutics, Inc.

company.status.inactive

CIK 1413797fmd_12JDMQAYWP71ZJ99RJNTW1V936Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2015, 22 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012FY2013FY2014
Total revenues––022
Cost of revenue00011
Gross profit00011
Research and development–0001
Selling, general and administrative111––
Operating income(1)(1)(1)(0)(2)
Interest expense01001
Other non-operating income (expense)(0)(0)(0)(0)(1)
Net income(2)(2)(1)(1)(3)
Net income to common shareholders–(2)(1)(1)(3)